Go Deep
TelyRx Holdings Inc.
TelyRx Holdings Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,509 | -3.4 | 4.09 | 1.24 | 159.70 |
| Oct 2026 | 19,517 | -3.4 | 4.07 | 1.24 | 158.97 |
TelyRx Holdings Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 22,670,000.0 | 19,394,000.0 | 14,314,000.0 | 12,337,000.0 |
| Net Profit | -4,469,000.0 | -4,676,000.0 | -3,099,000.0 | -1,059,000.0 |
| EPS | -0.2 | -0.2 | — | -0.0 |
TelyRx Holdings Inc. Revenue & Profit: Last 3 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 42,924,000.0 | 9,533,000.0 | 27,000.0 |
| Net Profit | -5,425,000.0 | -13,483,000.0 | -4,394,000.0 |
| EPS | -0.2 | -0.5 | -0.2 |
TelyRx Holdings Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Total Assets | 9,876,000.0 | 7,948,000.0 | 11,905,000.0 |
| Total Liabilities | 18,350,000.0 | 10,994,000.0 | 13,544,000.0 |
| Total Equity | -8,474,000.0 | -3,046,000.0 | -1,639,000.0 |
Owes vs Owns
TelyRx Holdings Inc. owed $0.65 for every $1 it owned in Jun 2026, down from $1.14 in Dec 2023.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.65× | 1.86× | 1.38× | 1.14× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
TelyRx Holdings Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 30.3%Receivables 4.6%Inventory 13.7%Fixed assets (tangible) 33.2%Intangible assets 10.5%Other assets 7.7%
How it's funded — Dec 2025
Short-term debt 50.0%Long-term debt 13.8%Payables 14.5%Other liabilities 21.8%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Assets | |||
| Cash & short-term investments | 3.0 | 3.3 | 0.2 |
| Receivables | 0.5 | 0.4 | 0.0 |
| Inventory | 1.4 | 0.5 | 0.1 |
| Fixed assets (tangible) | 3.3 | 2.5 | 1.1 |
| Intangible assets | 1.0 | 0.6 | 0.3 |
| Long-term investments | 0.0 | 0.0 | 0.0 |
| Other assets | 0.8 | 0.6 | 10.2 |
| Liabilities & equity | |||
| Short-term debt | 9.2 | 0.1 | 0.1 |
| Long-term debt | 2.5 | 7.2 | 5.5 |
| Payables | 2.7 | 0.9 | 0.1 |
| Other liabilities | 4.0 | 2.8 | 7.9 |
| Shareholders' equity | -8.5 | -3.0 | -1.6 |
| Net tangible assets | -9.5 | -3.7 | -1.9 |
TelyRx Holdings Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Operating Activities | -770,000.0 | -2,862,000.0 | -2,469,000.0 |
| Investing Activities | -1,442,000.0 | -1,429,000.0 | -359,000.0 |
| Financing Activities | 1,886,000.0 | 7,167,000.0 | 263,000.0 |